Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Molecular Characterization of Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT06096441 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT06096441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06096441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Molecular Characterization of Facioscapulohumeral Muscular Dystrophy (FSHD)
Lead sponsor
Nationwide Children's Hospital
Phase
Observational
Overall status
Terminated
Start date
March 5, 2021
Completion date
September 9, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facio-scapulo-humeral dystrophy